3 Canadian Growths Stocks Under $100 to Buy in February

Now’s the time to invest in growth stocks. These three top picks are all trading below $100 right now.

potted green plant grows up in arrow shape

Image source: Getty Images

Growth stocks, specifically tech companies, have not fared particularly well over the past 12 months. While the S&P/TSX Composite Index posted a 20% gain last year many top growth companies ended the year at a loss. Today, there’s no shortage of growth stocks on the TSX trading far below 52-week highs. 

Short-term investors may be hesitant to buy growth stocks in today’s volatile environment. It’s very possible that growth stocks will continue to slide even lower in the upcoming months. But if you’re investing for the long term, I’d strongly suggest putting some cash to work to take advantage of these discounted prices

I’ve put together a list of three market-beating growth stocks that are all trading at a discount. From a valuation standpoint, shares may not necessarily be cheap. But investors can own any of these three companies for less than $100 right now. 

Nuvei

Investors may not want to wait much longer to start a position in Nuvei (TSX:NVEI)(NASDAQ:NVEI). The tech stock is already up close to 30% from lows that were set two months ago.

A short report released in mid-December caused Nuvei to sell off an incredible 40% in a single day. While the report did include several serious allegations, shares have rebounded very well from that drop, highlighting investors’ confidence in the company.

Nuvei has only been a publicly traded company since late 2020. And even with a 40% selloff in December, shares are still up a market-crushing 75% since September 2020. 

Considering how well the growth stock has rebounded from its lows, I don’t think it will be long before Nuvei is back to trading at all-time highs. I’d act fast if you’re interested in this tech company.

WELL Health Technologies

Telemedicine stocks have not fared any better than tech companies over the past year. In the early days of the pandemic, telemedicine stocks surged, as demand for virtual health services skyrocketed. But as the world has slowly continued to return to pre-COVID life, demand for telemedicine services has dramatically cooled off. 

As a huge bull on the long-term growth opportunity of telemedicine, I couldn’t pass up these prices. I’m not a shareholder of WELL Health Technologies (TSX:WELL) yet but will be looking to add the company to my portfolio very soon.

The growth stock was up a whopping 400% in 2020. In comparison, the Canadian market was just about flat. Shares are currently down close to 50% over the past year, but WELL Health is still up close to 200% since the beginning of 2020.

Docebo

Last on my list is another high-priced tech stock that’s trading at an opportunistic discount. 

Similar to WELL Health, shares of Docebo (TSX:DCBO)(NASDAQ:DCBO) spiked at the beginning of the pandemic, due to a sudden rise in demand for the company’s products and services.

Docebo provides a range of different virtual learning platforms to customers spread across the globe. Unsurprisingly, the abrupt shift to remote work for many employees in 2020 caused a jump in demand for Docebo’s suite of virtual learning products.

Docebo is also relatively new to the public market, having only joined the TSX in late 2019. Since then, shares are up over 400%, easily outpacing the returns of the Canadian market. 

The tech stock is currently trading close to 40% from all-time highs. This is a buying opportunity that long-term investors won’t want to miss.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nicholas Dobroruka has no position in any of the stocks mentioned. The Motley Fool owns and recommends Nuvei Corporation. The Motley Fool recommends Docebo Inc.

More on Tech Stocks

Tech Stocks

Nvidia Stock Is Making History: Will It Make New Investors Any Money?

Nvidia stock (NASDAQ:NVDA) continues to surge past all-time highs, with shares up 265% in the last year alone! But can…

Read more »

Shopping and e-commerce
Tech Stocks

Shopify Stock Could Be a Major Generative AI Winner

Shopify (TSX:SHOP) stock could be a great gen AI stock pick for growth investors looking for a TFSA titan.

Read more »

woman analyze data
Tech Stocks

2 Tech Stocks I’d Buy in March 2024

High-growth tech stocks such as Datadog and Shopify should be on your shopping list in March 2024.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Growth Stocks to Hold for the Next 10 Years

Given their multi-year growth potential and attractive valuations, I am bullish on these two stocks.

Read more »

analyze data
Tech Stocks

If You’d Invested $500 in Nuvei Stock in 2020, This Is How Much You Would Have Today

Nuvei (TSX:NVEI) stock has seen its shares climb to triple digits and fall below IPO prices. So, what now for…

Read more »

Is Nvidia stock a buy?
Tech Stocks

Is Nvidia Stock a Buy After Its Huge Post-Earnings Surge?

Nvidia (Nasdaq:NVDA) stock jumped after the company’s phenomenal fourth-quarter earnings report, and everyone’s talking about a booming future for AI.…

Read more »

crypto, chart, stocks
Tech Stocks

2 Artificial Intelligence (AI) Stocks That Could Go Parabolic

Palantir Technologies stock and this tiny Canadian AI stock could rally as their new platforms bring new customers in 2024.

Read more »

growing plant shoots on stacked coins
Dividend Stocks

4 Ways to Grow $100,000 Into $1 Million in Retirement Savings

Anyone can build a million-dollar retirement portfolio. Here are four ways you could practically grow $100,000 to $1 million.

Read more »